NeuroPace Inc. is a medical technology company specializing in the development and commercialization of neurostimulation systems for the treatment of epilepsy. The company was founded in 1997 by a team of scientists and engineers with the goal of creating innovative solutions for individuals with epilepsy who are not adequately controlled by medications alone. NeuroPace is headquartered in Mountain View, California.
NeuroPace developed the RNS® System, which stands for Responsive Neurostimulation. It is an implantable device designed to detect and respond to abnormal electrical activity in the brain to reduce the frequency and severity of seizures. The RNS System is composed of a neurostimulator that is implanted under the scalp, connected to one or two leads that are surgically placed in the brain, and a programming system used by healthcare professionals to customize the device settings.
What sets the RNS System apart is its closed-loop approach to neurostimulation. Unlike traditional neurostimulation devices that provide continuous stimulation, the RNS System detects and responds to abnormal brain activity in real-time. When abnormal activity is detected, the device delivers small electrical pulses to the targeted area of the brain to disrupt the seizure activity. This personalized and adaptive approach allows for precise and tailored therapy for each patient.
The RNS System has the potential to significantly improve the quality of life for individuals with epilepsy. By providing an innovative treatment option for those who do not respond well to medications, the RNS System offers hope for better seizure management and increased seizure control. The device has demonstrated promising results in clinical trials, showing a reduction in seizure frequency and an improvement in overall well-being for patients.
NeuroPace is committed to ongoing research and development to advance the field of neuromodulation. The company collaborates with leading medical institutions and professionals to explore new applications and innovations in the treatment of neurological disorders. Through its dedication to improving the lives of individuals with epilepsy and its focus on technological advancements, NeuroPace continues to make significant contributions to the field of neurostimulation and personalized medicine.